These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20979701)

  • 21. Comparison of the effects of D-003, a mixture of high-molecular-weight aliphatic acids from sugarcane wax, and pravastatin on bones and osteoclast apoptosis of ovariectomized rats.
    Mendoza S; Noa M; Mas R; Mendoza N
    Drugs Exp Clin Res; 2005; 31(5-6):181-91. PubMed ID: 16425974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study.
    Coleman RE; Banks LM; Girgis SI; Vrdoljak E; Fox J; Cawthorn SJ; Patel A; Bliss JM; Coombes RC; Kilburn LS
    Breast Cancer Res Treat; 2010 Nov; 124(1):153-61. PubMed ID: 20730486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia.
    Chuengsamarn S; Rattanamongkoulgul S; Suwanwalaikorn S; Wattanasirichaigoon S; Kaufman L
    Bone; 2010 Apr; 46(4):1011-5. PubMed ID: 20045497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of simvastatin on the development of osteopenia caused by ovariectomy in rats.
    Pytlik M; Janiec W; Misiarz-Myrta M; Gubała I
    Pol J Pharmacol; 2003; 55(1):63-71. PubMed ID: 12856828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat.
    Luo S; Labrie C; Bélanger A; Labrie F
    Endocrinology; 1997 Aug; 138(8):3387-94. PubMed ID: 9231792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of aspirin administration for the treatment of osteoporosis in ovariectomized rat model].
    Chen ZW; Wu ZX; Sang HX; Qin GL; Wang LS; Feng J; Wang J; Li XJ; Wang JC; Zhang D
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(13):925-9. PubMed ID: 21600123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.
    Coleman RE; Banks LM; Girgis SI; Kilburn LS; Vrdoljak E; Fox J; Cawthorn SJ; Patel A; Snowdon CF; Hall E; Bliss JM; Coombes RC;
    Lancet Oncol; 2007 Feb; 8(2):119-27. PubMed ID: 17267326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women.
    Tanriverdi HA; Barut A; Sarikaya S
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):63-8. PubMed ID: 15866088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraosseous Injection of Simvastatin in Poloxamer 407 Hydrogel Improves Pedicle-Screw Fixation in Ovariectomized Minipigs.
    Fu X; Tan J; Sun CG; Leng HJ; Xu YS; Song CL
    J Bone Joint Surg Am; 2016 Nov; 98(22):1924-1932. PubMed ID: 27852910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
    Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of simvastatin on bone regeneration in the mandibles of ovariectomized rats and on blood cholesterol levels.
    Junqueira JC; Mancini MN; Carvalho YR; Anbinder AL; Balducci I; Rocha RF
    J Oral Sci; 2002 Dec; 44(3-4):117-24. PubMed ID: 12613499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olive oil in the prevention and treatment of osteoporosis after artificial menopause.
    Liu H; Huang H; Li B; Wu D; Wang F; Zheng Xh; Chen Q; Wu B; Fan X
    Clin Interv Aging; 2014; 9():2087-95. PubMed ID: 25506212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized rats.
    Goss PE; Qi S; Josse RG; Pritzker KP; Mendes M; Hu H; Waldman SD; Grynpas MD
    Bone; 2004 Mar; 34(3):384-92. PubMed ID: 15003786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer.
    Ellis GK; Bone HG; Chlebowski R; Paul D; Spadafora S; Smith J; Fan M; Jun S
    J Clin Oncol; 2008 Oct; 26(30):4875-82. PubMed ID: 18725648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.
    Liu J; Zhu LP; Yang XL; Huang HL; Ye DQ
    Bone; 2013 May; 54(1):151-6. PubMed ID: 23388418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.